Avesta76 Therapeutics

Avesta76 Therapeutics

by | Oct 1, 2013 | 0 comments

  Avesta76 is focused on a target that has the potential to treat every type of tumor. Market: Avesta76's therapies will address the need for safe and effective treatments across multiple cancers. This is a market with 17 million annual diagnoses, 10 million deaths,...
CDR3 Therapeutics, Inc.

CDR3 Therapeutics, Inc.

by | May 1, 2013

CDR3 develops stem cell-based immunotherapies to cure HPV-related cancers using chimeric antigen receptors or chronic viral infections using T cell receptors. Market:Today, we lack cures for most virus-related cancers and chronic viral infections, especially from...